Clinical Trials Browser

Uveal Melanoma × relatlimab × 90 days × Clear all

NCT04552223 2026-02-11

Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

Phase 2 Completed

27 enrolled 9 charts

Uveal Melanoma